July 22, 2025 02:00 ET | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…
London slips, Seoul crowned #1, Asia rises LONDON, July 15, 2025 /PRNewswire/ -- Seoul is crowned the world's best study…
Tailored solutions provide excellent water repellency while addressing key concerns such as fabric chalk mark defects and seam slippage HUNTERSVILLE,…